SCHEMBL9307802

SCHEMBL9307802

O=C=Nc1cnc2ccccc2n1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
HSD17B10 Q99714 2/20 0.43
ALOX15 P16050 1/20 0.43
PDE10A Q9Y233 1/20 0.42
NPC1 O15118 5/20 0.41
RAB9A P51151 4/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
BCHE P06276 1/20 0.41
KDM4E B2RXH2 3/20 0.40
GAA P10253 1/20 0.40
CASP1 P29466 1/20 0.40
MAPK10 P53779 1/20 0.40
CASP7 P55210 1/20 0.40
GPR3 P46089 1/20 0.39
HSP90AA1 P07900 2/20 0.39
HSP90AB1 P08238 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27796937 0.81 PDE10A (0.42) ALDH1A1HPGDHSD17B10ALOX15PDE10A
SCHEMBL3680526 0.78 ALDH1A1 (0.47) ALDH1A1HPGDHSD17B10ALOX15PDE10A
SCHEMBL9237384 0.77 PDE10A (0.50) ALDH1A1HPGDHSD17B10ALOX15PDE10A
SCHEMBL9362794 0.74 NPC1 (0.46) ALDH1A1HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL9704361 0.73 ALDH1A1 (0.43) ALDH1A1HPGDHSD17B10ALOX15PDE10A
SCHEMBL9181692 0.72 CYP3A4 (0.44) ALDH1A1HPGDHSD17B10
SCHEMBL30384637 0.71
SCHEMBL708434 0.71
SCHEMBL5658262 0.70 ALDH1A1 (0.49) ALDH1A1HPGDHSD17B10RAB9AMAPT
SCHEMBL95119 0.69 ALDH1A1 (0.47) ALDH1A1HPGDHSD17B10ALOX15PDE10A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020182929-A1 SUBSTITUTED UREAS AND DERIVATIVES AS NEW ANTIFUNGAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2020-09-17 WO claimed
WO-2012103520-A1 METHODS AND COMPOSITIONS FOR MODULATING CYCLOPHILIN D BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2012-08-02 WO claimed
WO-2020182929-A1 SUBSTITUTED UREAS AND DERIVATIVES AS NEW ANTIFUNGAL AGENTS BAYER AKTIENGESELLSCHAFT (DE) 2020-09-17 WO disclosed
WO-2012103520-A1 METHODS AND COMPOSITIONS FOR MODULATING CYCLOPHILIN D BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) 2012-08-02 WO disclosed
US-5318989-A Antitumor and -carcinogenic agents; antibiotics; aglycones of esperamycins and calichemicins and having the same mechanism of bioactivity BRISTOL-MYERS SQUIBB COMPANY (US) 1994-06-07 US disclosed
CN-1071912-A Dicyclo [7,3,1] 13 carbon-4-alkene-2,6-dialkyne and method for making thereof BRISTOL MYERS SQUIBB CO (US) 1993-05-12 CN disclosed
EP-0538898-A2 Cytotoxic bicyclo (7.3.1)-tridec-4-ene-2,6-diyne compounds and process for the preparation thereof Bristol-Myers Squibb Company (US) 1993-04-28 EP disclosed
US-5198560-A Antitumor agents based on esperamicin antibiotics BRISTOL-MYERS SQUIBB COMPANY (US) 1993-03-30 US disclosed